Michael Megna
Comptroller/Controller/Auditor presso KINIKSA PHARMACEUTICALS, LTD.
Patrimonio netto: 375 586 $ in data 30/04/2024
Posizioni attive di Michael Megna
Società | Posizione | Inizio | Fine |
---|---|---|---|
KINIKSA PHARMACEUTICALS, LTD. | Comptroller/Controller/Auditor | 04/02/2020 | - |
Direttore Finanziario/CFO | - | 17/12/2020 | |
Corporate Officer/Principal | 01/07/2018 | 04/02/2020 |
Storia della carriera di Michael Megna
Precedenti posizioni note di Michael Megna
Società | Posizione | Inizio | Fine |
---|---|---|---|
BioSphere Medical, Inc.
BioSphere Medical, Inc. Medical SpecialtiesHealth Technology BioSphere Medical, Inc. develops, manufactures and markets microsphere technology to medical applications. The company uses microsphere technology to develop its products for medical applications using embolotherapy techniques. It offers Embosphere Microspheres for uterine fibroids, hypervascularized tumors and other arteriovenous malformations, EmboGold Microspheres for Hypervascularized tumors and arteriovenous malformations, EmboCath Infusion Catheter and Segway Guidewire for peripheral embolization procedures and HepaSphere Microspheres for liver cancer. The company was founded in 1993 and is headquartered in Rockland, MA. | Comptroller/Controller/Auditor | 01/09/2004 | 01/11/2010 |
LFB USA, Inc.
LFB USA, Inc. Pharmaceuticals: MajorHealth Technology LFB USA, Inc. is a pharmaceutical company based in Framingham, MA. The company develops and provides pharmaceutical bioproducts through innovative technologies for patients with serious diseases. LFB USA is committed to improving people's lives by overcoming barriers through purposeful science. The company offers a robust set of services that powers its own pipeline to its partners. LFB USA's rpro technology is revolutionizing recombinant protein production for a new generation of therapeutics. The company is ultimately controlled by the Government of France. Jose Antonio Moreno Toscano has been the CEO of the company since 2018. | Comptroller/Controller/Auditor | - | - |
Formazione di Michael Megna
Siena College | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 5 |
Posizioni
Comptroller/Controller/Auditor | 3 |
Director of Finance/CFO | 1 |
Corporate Officer/Principal | 1 |
Settori
Health Technology | 4 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
KINIKSA PHARMACEUTICALS, LTD. | Health Technology |
Aziende private | 2 |
---|---|
BioSphere Medical, Inc.
BioSphere Medical, Inc. Medical SpecialtiesHealth Technology BioSphere Medical, Inc. develops, manufactures and markets microsphere technology to medical applications. The company uses microsphere technology to develop its products for medical applications using embolotherapy techniques. It offers Embosphere Microspheres for uterine fibroids, hypervascularized tumors and other arteriovenous malformations, EmboGold Microspheres for Hypervascularized tumors and arteriovenous malformations, EmboCath Infusion Catheter and Segway Guidewire for peripheral embolization procedures and HepaSphere Microspheres for liver cancer. The company was founded in 1993 and is headquartered in Rockland, MA. | Health Technology |
LFB USA, Inc.
LFB USA, Inc. Pharmaceuticals: MajorHealth Technology LFB USA, Inc. is a pharmaceutical company based in Framingham, MA. The company develops and provides pharmaceutical bioproducts through innovative technologies for patients with serious diseases. LFB USA is committed to improving people's lives by overcoming barriers through purposeful science. The company offers a robust set of services that powers its own pipeline to its partners. LFB USA's rpro technology is revolutionizing recombinant protein production for a new generation of therapeutics. The company is ultimately controlled by the Government of France. Jose Antonio Moreno Toscano has been the CEO of the company since 2018. | Health Technology |
- Borsa valori
- Insiders
- Michael Megna
- Esperienza